<?xml version="1.0" encoding="UTF-8"?><!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com --><!-- Created: Tue Jun 23 20:05:34 UTC 2026 --><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:common="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002131472</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common stock, $0.001 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>06/30/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001611115</issuerCik>
        <issuerName>Omada Health, Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>68170A108</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <common:street1>611 Gateway Blvd.</common:street1>
          <common:street2>Suite 120</common:street2>
          <common:city>South San Francisco</common:city>
          <common:stateOrCountry>CA</common:stateOrCountry>
          <common:zipCode>94080</common:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>The Cigna Group</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>3444630</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>3444630</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>3444630</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>5.8</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Cigna Ventures, LLC</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>3444630</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>3444630</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>3444630</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>5.8</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Omada Health, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>611 Gateway Blvd., Suite 120, South San Francisco, CA 94080</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This statement is filed by the following entities and individuals (collectively, referred to as the "Reporting Persons"):

The Cigna Group

Cigna Ventures, LLC</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The address of the principal business office for each of the Reporting Persons is 900 Cottage Grove Rd., Bloomfield, CT 06002.</principalBusinessOfficeOrResidenceAddress>
        <citizenship>The citizenship of each of the Reporting Persons is: Delaware.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>Cigna Ventures, LLC is a wholly owned subsidiary of The Cigna Group, and The Cigna Group may be deemed to have shared voting and dispositive power with respect to the shares held by Cigna Ventures.

Amount beneficially owned: 3,444,630</amountBeneficiallyOwned>
        <classPercent>5.8%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>0.00</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>3,444,630</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>0.00</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>3,444,630</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>The Cigna Group</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Andrea Nelson</signature>
        <title>Executive Vice President, General Counsel and Corporate Secretary</title>
        <date>06/23/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Cigna Ventures, LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Craig Cimini</signature>
        <title>President</title>
        <date>06/23/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>

</edgarSubmission>
